PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis?

Am J Respir Crit Care Med. 2023 Jun 15;207(12):1643-1644. doi: 10.1164/rccm.202303-0355LE.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cells, Cultured
  • Fibrosis
  • Humans
  • Proprotein Convertases
  • Pulmonary Fibrosis* / drug therapy
  • Serine Endopeptidases

Substances

  • Serine Endopeptidases
  • PCSK6 protein, human
  • Proprotein Convertases